Day Long Prevention of Oral Malodor With a Palatal Patch (SmellX) Containing A Herbal Formula

NCT ID: NCT01388023

Last Updated: 2012-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-01-31

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In a previous study the prevention of halitosis by the herbal formula and delivery system (SmellX), were established both in vitro and clinicaly. The duration of relief was established as long as 8 hours. In this study the investigators intend examine the day long efficacy of SmellX.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Oral malodor is a common complaint among dental patients. This condition derives in most cases form the putrefactive activities of oral microorganisms, primarily anaerobic Gram negative bacteria. These bacteria reside on various locations within the oral cavity (e.g. tongue dorsum, interdental space, periodontal pockets, faulty and leaky restorations and tonsils) and breakdown salivary and oral proteins into their amino acid building blocks. Some of these amino acids (e.g. methionine and cysteine) are further metabolized yielding malodorous volatile sulfide compounds (VSC) such as methylmercaptan and hydrogen sulfide.The tongue dorsum and especially its posterior portion are considered the key location for this process. Therefore, the treatment regiment includes in most cases a daily use of tongue scrapers and mouthwashes. Indeed, a recent Cochrane systematic review found tongue scrapers to have short-term efficacy in controlling halitosis.

However, the use of tongue scrapers is unpleasant and induces in many cases a strong gag reflex, and apparently has very little effect on bacterial load of the tongue.

Furthermore, some mouthwashes have been shown to cause adverse side effects such as tooth staining. In a previous study we performed a set of related experiments on a new sustained release delivery system in the form of an adhesive tablet containing an herbal formulation. The adhesive tablet is applied to the palate. This places it right above, and in direct contact with the tongue dorsum, thus allowing a sustained release of the active ingredients directly to the target site. The ingredients of the herbal formulation have been previously shown to reduce malodor production in a salivary incubation assay. We tested the effect of this system on oral malodor production and VSC levels in a young healthy population, and the antimicrobial effect of its active ingredients on three known oral pathogens (Streptoccocus mutans, Porphyromonas gingivalis and Candida albicans. In this study we intend to examine a day long protocol to achieve a relief from oral halitosis for 24 houres.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Halitosis Gingivitis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

SmellX malodor halitosis herbal formulation natural medicinals slow release delivery system gingivitis Bad Breath

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

smellx

test group- SmellX palatal patch with the herbal formula

Group Type ACTIVE_COMPARATOR

herbal formula for fresh breath

Intervention Type DIETARY_SUPPLEMENT

composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria

smellx palatal patch

negative control group- SmellX palatal patch with out the herbal formula

Group Type PLACEBO_COMPARATOR

herbal formula for fresh breath

Intervention Type DIETARY_SUPPLEMENT

composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria

chlorhexidine

poositive control group-mouth wash with chlorhexidine 0.125%

Group Type ACTIVE_COMPARATOR

herbal formula for fresh breath

Intervention Type DIETARY_SUPPLEMENT

composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria

listerine

listerine mouth wash

Group Type ACTIVE_COMPARATOR

herbal formula for fresh breath

Intervention Type DIETARY_SUPPLEMENT

composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

herbal formula for fresh breath

composition of herbal ingridients in a palatal mucoadhesive patch to remove volatile solfur compounds and reducequantity of vsc creating bacteria

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

chlorhexidine listerine diclosan

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* random gender
* age
* healthy people

Exclusion Criteria

* used antibiotics in the last three months
* suffer from systemic disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hadassah Medical Organization

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hadassah Medical Centers

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael M Perez Davidi, DMD

Role: PRINCIPAL_INVESTIGATOR

Hadassah Medical Centers The hebrew university Jerusalem

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hadassah Medical Organization,

Jerusalem, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

References

Explore related publications, articles, or registry entries linked to this study.

Perez Davidi M, Beyth N, Sterer N, Feuerstein O, Weiss EI. Effect of liquid-polish coating on in vivo biofilm accumulation on provisional restorations: part 1. Quintessence Int. 2007 Jul-Aug;38(7):591-6.

Reference Type BACKGROUND
PMID: 17694216 (View on PubMed)

Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci. 2004 Dec;93(12):2927-35. doi: 10.1002/jps.20193.

Reference Type RESULT
PMID: 15459950 (View on PubMed)

Sterer N, Rubinstein Y. Effect of various natural medicinals on salivary protein putrefaction and malodor production. Quintessence Int. 2006 Sep;37(8):653-8.

Reference Type RESULT
PMID: 16922026 (View on PubMed)

Sterer N. Antimicrobial effect of mastic gum methanolic extract against Porphyromonas gingivalis. J Med Food. 2006 Summer;9(2):290-2. doi: 10.1089/jmf.2006.9.290.

Reference Type RESULT
PMID: 16822220 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mypd.co.il

Dr.Michael Perez Davidi

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1910552HMO-CTIL

Identifier Type: -

Identifier Source: org_study_id